SEPN · Septerna, Inc.

$40.79 -3.14 (-7.15%) At close · Aug 20

Market Cap

$1.89B

46.68M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gil M. Labrucherie	CFA, J.D. Chief Financial Officer	$479,489	$223,100	—	$2,535,337	—	$2,425	$3,240,351
Jeffrey Finer	M.D., Ph.D Chief Executive Officer	$635,000	$401,638	—	$1,891,701	—	$5,000	$2,933,339
Liz Bhatt	M.S., M.B.A President and Chief Operating Officer	$500,000	$230,000	—	$855,770	—	$5,000	$1,590,770

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jeffrey Finer	M.D., Ph.D. Chief Executive Officer	$550,193	$365,878	—	$3,801,342	—	$3,000	$4,720,413
Jae B. Kim	Chief Medical Officer	$125,057	$108,117	—	$1,633,384	—	$3,000	$1,869,558
Liz Bhatt	M.S., M.B.A. Chief Operating Officer	$449,559	$209,270	—	$956,832	—	$3,000	$1,618,661

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jeffrey Finer	M.D., Ph.D. Chief Executive Officer	$501,396	$284,310	—	$1,347,554	—	$3,000	$2,136,260
Liz Bhatt	M.S., M.B.A. Chief Operating Officer	$413,253	$203,270	—	$264,173	—	$3,000	$883,696

Executive changes

Person	Role	Change	Effective	Filed
Keith Gottesdiener, M.D.	member of the Board and as a Class I director	Appointed	2025-09-25	2025-09-29
Liz Bhatt, M.S., M.B.A.	President	Appointed	2025-08-01	2025-08-04
Gil M. Labrucherie	Chief Financial Officer, principal financial officer and principal accounting officer	Appointed	2025-01-06	2025-01-06

Key facts CIK 1984086 CUSIP 81734D104 13F (30d) 153 filings 151 filers Visit website Investor relations